Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease (HUPrevent)

This study is currently recruiting participants.

Verified March 2012 by Johns Hopkins University

Sponsor:

Collaborators:

Washington University School of Medicine

Vanderbilt University School of Medicine

University of Alabama at Birmingham

Children's Hospital of Philadelphia

Children's Hospital Medical Center, Cincinnati

Medical University of South Carolina

RTI International

Information provided by (Responsible Party):

James Casella, Johns Hopkins University

ClinicalTrials.gov Identifier:

NCT01389024

First received: June 30, 2011

Last updated: March 14, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	October 2015
Estimated Primary Completion Date:	October 2015 (Final data collection date for primary outcome measure)